Skip to content

The clinical trials and research programme of the new technology of intestinal tube

The clinical trials and research programme of the new technology of intestinal tube

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002598
Enrollment
Unknown
Registered
2012-09-24
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The stomach, liver, gallbladder, acuter pancreas, spleen, colonic operation

Interventions

study group:Liquid bag jejunum catheter
control group:Flocare spiral nasointestinal feeding tube

Sponsors

Tongde hospital of Zhejiang province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1 age over 18, sex not limited;2 For the stomach, liver, gallbladder disease, pancreas, spleen, colonic operation, severe acute pancreatitis, senile dementia and other diseases for treatment of intestinal tube. And all are in accordance with the enteral nutrition support indications;3 expected survival time is more than 3 months;4 subjects are inpatients, and signed informed consent.

Exclusion criteria

Exclusion criteria: Upper gastrointestinal bleeding, severe malabsorption syndrome, intra-abdominal infections, short bowel syndrome and intestinal complete rest patients.240

Design outcomes

Primary

MeasureTime frame
Pneumonia (person-time);Gastric paralysis (person-time);Anastomotic leakage (person-time);Mortality;

Countries

China

Contacts

Public ContactChen yiqi
718md@sina.com+86 057189972360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026